Sign in to view content

Real World Experience of Brolucizumab for Persistent Macular Fluid in Neovascular Age-Related Macular Degeneration After Prior Anti-VEGF Treatments

Rehan M. Hussain, MD

Video
Published 2021

Related

A Comparison of the Anatomical Efficacy of Brolucizumab Versus Aflibercept in nAMD Patients: Matched 16-Week Results From the HAWK and HARRIER Studies
Pravin U. Dugel, MD
Annual Meeting Talks
2018
Incidence of New Choroidal Neovascularization in Fellow Eyes of Patients Treated With Intravitreal Aflibercept or Ranibizumab in the VIEW studies
Robert L. Avery, MD
On Demand Cases, Courses, and Papers
2017
Wieland-Khanani Port Delivery System
Mark R. Wieland, MD
Arshad M. Khanani, MD, MA, FASRS
Updates from the Field

Category: AMD-Neovascular

See more